Alwin G. Schuller
AstraZeneca (United States)(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Immune cells in cancer, Gastric Cancer Management and Outcomes, HER2/EGFR in Cancer Research, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974(2013)825 cited
- → Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia(2018)480 cited
- → Retention of Supraspinal Delta-like Analgesia and Loss of Morphine Tolerance in δ Opioid Receptor Knockout Mice(1999)432 cited
- → Retention of heroin and morphine–6β–glucuronide analgesia in a new line of mice lacking exon 1 of MOR–1(1999)305 cited
- → Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy(2013)169 cited
- → Diminished Growth and Enhanced Glucose Metabolism in Triple Knockout Mice Containing Mutations of Insulin-Like Growth Factor Binding Protein-3, -4, and -5(2006)162 cited